Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.

Nunley KS, Gao F, Albers AC, Bayliss SJ, Gutmann DH.

Arch Dermatol. 2009 Aug;145(8):883-7. doi: 10.1001/archdermatol.2009.169.

PMID:
19687418
2.

The diagnostic and clinical significance of café-au-lait macules.

Shah KN.

Pediatr Clin North Am. 2010 Oct;57(5):1131-53. doi: 10.1016/j.pcl.2010.07.002. Review.

PMID:
20888463
3.

The diagnostic value of café-au-lait macules.

Landau M, Krafchik BR.

J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):877-90; quiz 891-2. Review.

PMID:
10365918
4.

Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas.

Overdiek A, Feifel H, Schaper J, Mayatepek E, Rosenbaum T.

Brain Dev. 2006 Jun;28(5):275-80. Epub 2006 Feb 14. Review.

PMID:
16481142
5.

Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.

Bernier A, Larbrisseau A, Perreault S.

Pediatr Neurol. 2016 Jul;60:24-29.e1. doi: 10.1016/j.pediatrneurol.2016.03.003. Epub 2016 Mar 19. Review.

PMID:
27212418
6.

[Neurofibromatosis in children. Our experience].

López-Pisón J, Cuadrado-Martín M, Boldova-Aguar MC, Muñoz-Mellado A, Cabrerizo de Diago R, Peña-Segura JL.

Rev Neurol. 2003 Nov 1-15;37(9):820-5. Review. Spanish.

7.

Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.

Thiagalingam S, Flaherty M, Billson F, North K.

Ophthalmology. 2004 Mar;111(3):568-77. Review.

PMID:
15019338
8.

[Imaging features of neurofibromatosis type 1].

Jacques C, Dietemann JL.

J Neuroradiol. 2005 Jun;32(3):180-97. Review. French.

PMID:
16134300
9.

The Neurofibromatoses. Part 1: NF1.

Lu-Emerson C, Plotkin SR.

Rev Neurol Dis. 2009 Spring;6(2):E47-53. Review.

PMID:
19587630
10.

MRI diagnosis of NF-1 in children without café-au-lait skin lesions.

Curless RG, Siatkowski M, Glaser JS, Shatz NJ.

Pediatr Neurol. 1998 Mar;18(3):269-71. Review.

PMID:
9568928
11.

[Syndromes 18. Von Recklinghausen's disease].

Baart JA, van Hagen JM.

Ned Tijdschr Tandheelkd. 2000 Feb;107(2):57-9. Review. Dutch.

PMID:
11385791
12.

Diagnosing neurofibromatosis type I in children.

Davis RE.

Nurse Pract. 1997 Apr;22(4):73-6, 79-81. Review.

PMID:
9128879
13.

Pigment cell-related manifestations in neurofibromatosis type 1: an overview.

De Schepper S, Boucneau J, Lambert J, Messiaen L, Naeyaert JM.

Pigment Cell Res. 2005 Feb;18(1):13-24. Review.

PMID:
15649148
14.

Gliomas in patients with neurofibromatosis type 1.

Albers AC, Gutmann DH.

Expert Rev Neurother. 2009 Apr;9(4):535-9. doi: 10.1586/ern.09.4. Review.

PMID:
19344304
15.

[Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].

Sabol Z, Kipke-Sabol L.

Lijec Vjesn. 2005 Nov-Dec;127(11-12):303-11. Review. Croatian.

PMID:
16583938
16.

Legius syndrome, an Update. Molecular pathology of mutations in SPRED1.

Brems H, Legius E.

Keio J Med. 2013;62(4):107-12. Epub 2013 Dec 10. Review.

17.

Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1.

Cnossen MH, Stam EN, Cooiman LC, Simonsz HJ, Stroink H, Oranje AP, Halley DJ, de Goede-Bolder A, Niermeijer MF, de Muinck Keizer-Schrama SM.

Pediatrics. 1997 Oct;100(4):667-70. Review.

PMID:
9310522
18.

Incidence, types, and management of cancer in patients with neurofibromatosis.

Cohen BH, Rothner AD.

Oncology (Williston Park). 1989 Sep;3(9):23-30; discussion 34, 37-8. Review.

PMID:
2518324
19.

Neurofibromatosis type 1.

Boyd KP, Korf BR, Theos A.

J Am Acad Dermatol. 2009 Jul;61(1):1-14; quiz 15-6. doi: 10.1016/j.jaad.2008.12.051. Review.

20.

Molecular screening strategies for NF1-like syndromes with café-au-lait macules (Review).

Zhang J, Li M, Yao Z.

Mol Med Rep. 2016 Nov;14(5):4023-4029. doi: 10.3892/mmr.2016.5760. Epub 2016 Sep 22. Review.

Supplemental Content

Support Center